Pimozide is an atypical antipsychotic drug used to treat serious motor and verbal tics associated with Tourette's syndrome. It is sold under the brand name Orap.
Pimozide is classified as an atypical antipsychotic drug. It is structurally similar to another drug, haloperidol, which was the first drug to be used in Tourette's syndrome. Pimozide is most often used to treat symptoms of Tourette's syndrome, although it has also been used for treating schizophrenia mania, and other behavioral disorders.
Excess dopamine activity in the brain is associated with the verbal and physical tics observed in Tourette's syndrome. Like haloperidol, pimozide is believed to inhibit the actions of the brain chemical, dopamine.
Pimozide is broken down by the liver and eliminated from the body by the kidneys. Because pimozide is associated with health risks, it should not be used for tics that are simply annoying or cosmetic. Pimozide should be used only in patients with severe symptoms after other drug therapy has been tried and failed.
Pimozide is available in 1-mg and 2-mg tablets.
The common starting dose of pimozide in adults is 1-2 mg per day. The dose may be increased every other day until 0.2 mg per kg (or 0.9 mg per pound) of body weight per day or 10 mg per day is reached, whichever is less. Doses that exceed 0.2 mg per kg per day or 10 mg daily are not recommended.
In children, the usual initial dose is 0.05 mg per kg daily, and increased every three days to a maximum dose of 0.2 mg per kg (or 10 mg) per day.
Periodically, the dosage of pimozide should be reduced to determine if tics are still present. Patients should be maintained on the lowest dose that is effective in treating their disorder.
|
|
Author Info: Kelly Karpa RPh, Ph.D., The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Mental Disorders, 2003 |